Continuing Medical Education for Healthcare Professionals

Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Results 1 - 59 of 59

Improving the Diagnosis and Management of PPF: Rapid Recap

Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF

9360-0001_263x149

Improving the Management of Patients with PPF - Slide Library

MicrosoftTeams-image (18)

Coordinating Care for Patients With Progressive Pulmonary Fibrosis - Rapid Recap

MicrosoftTeams-image (18)

Coordinating Care for Patients With Progressive Pulmonary Fibrosis - Slide Deck

MicrosoftTeams-image (18)

Coordinating Care for Patients With Progressive Pulmonary Fibrosis

Providing a Medical Home for Kids with Rare Lung Disease

SSc-ILD With Rapid Progression

Delayed Diagnosis of SSc-ILD with PPF

Identifying the Signs and Symptoms of PPF

Am I Treating My Patients With Psoriatic Disease Effectively?

Am I Treating My Patients with Psoriatic Disease Effectively?

9088-sscild-slides

Practical Solutions to SSc-ILD Treatment - Slide Deck

Practical Solutions to SSc-ILD Treatment

SSc-ILD Individualized Treatment

Fundamentals of Diagnosis: SSc-ILD

Rheumatic Learning: Next Steps for Mr. S's Established RA

Rheumatic Learning: Next Steps for Mrs. J's Early RA

Rheumatic Learning: How Can You Help Jeff With His Psoriatic Arthritis?

Rheumatic Learning: How can you help Andrea with her Psoriatic Arthritis?

Practical Applications From What We Heard at Virtual ACR

Monitoring for Changes in Disease Course and Comorbidities in SSc ILD

New Directions in the Diagnosis of RA ILD

Therapies on the Horizon for RA ILD

New Treatment Options for SSc ILD

Updates on Current Treatment Options for RA ILD

Biochemical Profiles of Radiographic Patterns in SSc-ILD

Factors Associated with Disease Progression in the SENSCIS Trial

Machine Learning Assisted Prediction of Progression in SSc-ILD

What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD

Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD

Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis

Updates on Current Treatment Options for RA-ILD

Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib

Monitoring for Changes in Disease Course and Comorbidities in SSc ILD

The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring

The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence

The Essential Role of Primary Care in SLE

A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting

9907-0006_shared

Engage Your Patients in Shared Decision-Making

9907-0005_cardio

Is It IPF or Cardiovascular Disease?

Interstitial Pneumonia with Autoimmune Features

9907-0003_pf-ild

How to Identify Progressive Fibrosing ILD

When Is It a Connective Tissue Disease?

biosims-archmed icon2

Top Questions about Biosimilars in Rheumatology

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Biosimilars in Clinical Practice: Interchangeability and Extrapolation